GH-axis research
GHRP-6
Gevriesdroogd endocriene signaleringsonderzoekpeptide voor systeembeoordeling
GHRP-6 is an early growth hormone releasing peptide used as a reference point in GH secretagogue literature.
Support can confirm any currently available COAs or batch documentation for this product.
Request available documentsConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesAlleen voor laboratoriumonderzoek. Niet voor menselijk of diergeneeskundig gebruik. Niet bedoeld voor het diagnosticeren, behandelen, genezen, verzachten of voorkomen van ziekten.
Afgesloten, koud, droog en beschermd tegen hitteschommelingen bewaren. Bevestig productspecifieke opslag bij aankomst.
Verpakt voor stabiliteit tijdens het transport, met bestelondersteuning beschikbaar voor routes bij warm weer.
Batch-linked certificate support is available through the documentation desk.
Onderzoekscontext
GHRP-6 onderzoeksprofiel
GHRP-6 is an early synthetic growth hormone-releasing peptide used as a reference in ghrelin-receptor and GH-secretagogue research. Experimental studies measure GH response, receptor signaling, endocrine markers, appetite-related pathways, and differences from GHRP-2, ipamorelin, hexarelin, or GHRH analogs. It is commonly chosen when a project needs a historically established GHS-R comparator with a broad physiological research record. Because secretagogues can differ in selectivity and off-target endocrine observations, compounds should not be treated as interchangeable. Findings from older human or animal studies describe their specific materials and protocols and do not establish the suitability or performance of a separate catalog product.
Molecular class
Six-residue GH secretagogue
Sequence / composition
His-D-Trp-Ala-Trp-D-Phe-Lys-NH2; a hexapeptide containing D-tryptophan and D-phenylalanine.
Research design note
Its historical GHS-R profile makes direct comparison with newer secretagogues a frequent research use case.
Voorgesteld mechanisme
A synthetic GHS-R1a agonist that stimulates growth-hormone release and activates central ghrelin-related appetite pathways. It also has measurable endocrine activity beyond GH in some models.
In studies gerapporteerde effecten
- Human and animal studies reported acute GH release and increased food intake or appetite-related signaling.
- Some studies observed increases in cortisol or prolactin, demonstrating lower endocrine selectivity than a purely GH-specific ligand.
- Responses can diminish or change with repeated exposure and depend on endogenous GHRH and somatostatin tone.
Veelgebruikte onderzoekseindpunten
GHS-R activation, GH, ACTH, cortisol, prolactin, food intake, hypothalamic signaling, glucose, receptor desensitization, and interaction with GHRH.
Bewijs en beperkingen
The acute endocrine and appetite-related effects are documented in preclinical and human pharmacology studies. Long-term safety and product equivalence remain unestablished.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Support and documentation
Questions about this product?
Where can I find product documentation?
Contact support with the product name and any relevant order or batch reference to request available documents.
How can I compare pack options?
Where multiple pack sizes are available, Azure shows the price per listed vial so you can compare catalog value directly.